Do the Advantages of the FiberNet® Embolic Protection Device Translate into Technical Success and Comparable Event Rates in Carotid Artery Stenting?

Abstract

FiberNet® is a second generation non-conventional embolization protection device (EPD) that purports to offer several advantages: ability to capture debris as small as 40 μm, more flexibility with placement and positioning in curved segments requiring a small landing zone, ability to conform to asymmetric vessels, and improved deliverability. The design features a low profile with large surface area to capture debris. Legitimate concerns include inducement of obstruction or low flow with debris capture and requirements in the IFU to aspirate during re-capture and device removal. Our goal was to compare the results of carotid artery stenting (CAS) using FiberNet® against a multi-center experience of CAS using other filter devices to identify any differences in technical success or event rates. FiberNet® (n=25) results were compared to all CAS cases performed at the Mayo Clinic in Rochester, MN, St Mary's/Duluth Clinic in MN, and North Central Heart Institute in Sioux Falls, SD (n=250) from March 2001 to December 2008. Chi-square or means were used to compare variables, as appropriate. Bivariate logistic regression was used to identify possible correlates of adverse outcome. Statistical significance was set at < 0.05. FiberNet® patients were more likely to be older (78.1+5.4 vs 73.6+9.4, p=0.019), female (48% vs 29%, p=0.047), and have peripheral vascular disease (84.0% vs 37.2%, p=0.025), and less likely to have diabetes (8.0% vs 29.8%, p=0.012) than patients in the comparison group. FiberNet® patients had more lesion calcification (40.0% vs 18.9%, p=0.014) and increased number of type 2 and 3 arches (44.2% vs 73.9%, p=0.006). Procedural success rate was 100% in both groups. None of the FiberNet® patients showed evidence of stagnant flow. The thirty-day outcome for TIA, CVA, or death was 4% in FiberNet® versus 4.8% in the comparison group (p NS). None of the independent variables – age gender, serum creatinine, arch complexity, lesion length, lesion calcium, lesion thrombus, PVD, diabetes, contralateral carotid occlusion, or ipsilateral carotid endarterectomy – predicted adverse events. Although FiberNet® patients had more lesion calcium and more challenging arch anatomy, procedural success and adverse events were comparable between groups. The advantages of FiberNet® can be applied to CAS with good technical results and may be a promising EPD for certain high-risk situations.

Keywords

carotid artery stent embolic protection device carotid disease fibernet

Get full access to this article

View all access options for this article.

References

Dorros

: Carotid arterial obliterative disease: Should endovascular revascularization (stent supported angioplasty) today supplant carotid endarterectomy? J Interv Cardiol 9: 193–196, 1996.

Eastcott

HHG

Pickering

Rob

: Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 267: 994–996, 1954.

North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of the carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325: 445–453, 1991.

European Carotid Surgery Trialists' Collaborative Group: MRC European Carotid Surgery Trial: Interim Results for symptomatic patients with severe (70–90%) or with mild (0–29%) carotid stenosis. Lancet 337: 1235–1243, 1991.

Executive Committee for the asymptomatic carotid atherosclerotic study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273: 1421–1428, 1995.

MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group Prevention: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 363: 1491–1502, 2004.

Hobson

Weiss

Fields

: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis: The Veterans Affairs Cooperative Study Group. N Engl J Med 328: 221–227, 1993.

Ouriel

Hertzer

Beven

: Preprocedural risks stratification: Identifying an appropriate population for carotid stenting. J Vasc Surg 33: 728–732, 2001.

Ohki

Roubin

Veith

: Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting. An ex-vivo analysis. J Vasc Surg 30(6): 1034–1044, 1999.

10.

Al Mubarak

Roubin

Vitek

: Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 104: 1999–2002, 2001.

11.

Jordan

Voellinge

RDC

Doblar

: Micro-emboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg 7: 33–39, 1997.

12.

Vitek

Raymon

: Innominate artery angioplasty. Am J Neuroradiol 5: 113–114, 1984.

13.

Theron

Raymon

Casasio

: Percutaneous angioplasty of atherosclerotic and post-surgical stenosis of carotid arteries. Am J Neuroradiol 8: 495–500, 1987.

14.

Henry

Amor

Henry

: Carotid stenting with cerebral protection: First clinical experience using the Percusurge Guardwire System. J Endovasc Surg 6: 321–331, 1999.

15.

Henry

Klonaris

: Benefits of cerebral protection during carotid stenting with the Percusurge Guardwire System: Mid-term results. J Endovasc Ther 9: 1–13, 2002.

16.

Parodi

Lamura

Ferreira

: Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg 32: 1127–1136, 2000.

17.

Reimers

Corvaja

Moshiriss : Cerebral protection with filter devices during carotid artery stenting. Circulation 104: 12–15, 2001.

18.

Wholey

Al Mubarak

Wholey

: Updated review of the global carotid artery stent registry. Cathet Cardiovasc Interv 60: 259–266, 2003.

19.

Cremonesi

Manetti

Setacci

: Protected carotid stenting: Clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 34(8): 1936–1941, 2003.

20.

Reimers

Schlueter

Castriota

: Routine use of cerebral protection during carotid artery stenting: Results of a multicenter registry of 753 patients. Am J Med 116: 217–222, 2004.

21.

Kastrup

Groschel

Frapf

: Early outcome of carotid and stenting with and without cerebral protection devices: A systemic review of the literature. Stroke 34(3): 813–819, 2003.

22.

Yadav

Wholey

Kuntz

: Protected carotid artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351: 1493–1501, 2004.

23.

Henry

Polydorou

Henry

: Carotid angioplasty under protection with the Percusurge Guardwire device. In: Henry

Ohki

, editors. Angioplasty and Stenting of the Carotid and Supra-Aortic Trunks. Taylor and Francis: London 2004: 485–496.

24.

Parodi

Bates

Schonholz

: Parodi embolization system: Description and first results. In: Henry

Ohki

, editors. Angioplasty and Stenting of the Carotid and Supra-Aortic Trunks, Taylor and Francis: London 2004: 523–530.

25.

CARESS steering Committee: Carotid revascularization using endarterectomy or stenting systems (CARESS): Phase I clinical trial. J Endovasc Ther 10: 1021–1030, 2003.

26.

Flach

Ouhlous

Hendricks

: Cerebral ischemia after carotid intervention. J Endovasc Ther 11: 251–257, 2004.

27.

Reimers

Sievert

Schuler

: Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: Results from a prospective multicenter registry. J. Endovasc Ther 12: 156–165, 2005.

28.

Brooks

McLure

Jones

: Carotid angioplasty and stenting versus carotid endarterectomy: Randomized trial in a community hospital. J Am Coll Cardiol 38: 1589–1595, 2001.

29.

Wholey

Mathias

: Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 50: 160–167, 2000.

30.

Martin

Pache

Treggiari-Venzi

: Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke 32: 497–484, 2001.

31.

Théron

Payelle

Coskun

: Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement. Radiology 201: 627–636, 1996.

32.

Al-Mubarak

Colombo

Gaines

: Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol 39: 841–846, 2002.

33.

Schluter

Tubler

Mathey

: Feasibility and efficacy of balloon-based neuroprotection during carotid artery stenting in a single-center setting. J Am Coll Cardiol 40: 890–895, 2002.

34.

Wholey

: The ARCHeR trial: Prospective clinical trial for carotid stenting in high surgical risk patients, preliminary thirty-day results. Presented at the 52^nd Annual Meeting of the American College of Cardiology; Chicago, IL, USA 2003: March 30.

35.

Whitlow

: Security: Multicenter registry in high-risk symptomatic and asymptomatic carotid disease with the Abbott Xact stent and MedNova filter. Presented at Transcatheter Cardiovascular Therapeutics (TCT); Washington, DC, USA 2003: September 15–19.

36.

Adami

Scuro

Spinamano

: Use of the Parodi anti-embolism system in carotid stenting: Italian trial results. JEndovasc Ther 9: 147–154, 2002.

37.

Sievert

: Embolic protection during carotid stenting with the new FiberNet device. Catheter Cardiovasc Interv 69(7): 1026–35, 2007.